Skip to main content
DYN
NASDAQ Life Sciences

Affiliate ForDyne B.V. Files Intent to Sell $15.9M in Dyne Therapeutics Shares

Analysis by Wiseek AI
Sentiment info
Negative
Importance info
7
Price
$20
Mkt Cap
$3.299B
52W Low
$6.36
52W High
$25
Market data snapshot near publication time

Summary

An affiliate of Dyne Therapeutics, ForDyne B.V., has filed a Form 144 to sell approximately $15.9 million worth of common stock, continuing a recent trend of share dispositions.


Key Events

  • Significant Intent to Sell

    ForDyne B.V., an affiliate, has filed a Form 144 indicating its intent to sell 807,295 shares of common stock, valued at approximately $15.9 million.

  • Continuation of Share Distribution

    This proposed sale follows previous dispositions by ForDyne B.V., which has already sold 688,788 shares totaling over $13.1 million in gross proceeds over the past three months, as noted in the filing and recent insider activity.

  • Affiliate Status

    The seller, ForDyne B.V., is identified as an affiliate, suggesting a significant shareholder rather than an operational executive.


Analysis

This Form 144 indicates that ForDyne B.V., an affiliate, intends to sell a substantial block of Dyne Therapeutics shares. This follows a pattern of distribution by this entity, with over $13 million in sales already executed in the past three months. While this proposed sale represents potential dilution, it appears to be a planned liquidation by a significant shareholder rather than a sudden loss of confidence from an operational insider. Investors should monitor the actual sales as they occur.

At the time of this filing, DYN was trading at $20.00 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $3.3B. The 52-week trading range was $6.36 to $25.00. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

DYN - Latest Insights

DYN
Jun 08, 2026, 4:05 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $16.81
Real-time Price: $17.95 info
Change: +$1.14 (+7%) info
Market Cap: $2.967B info
DYN
Jun 03, 2026, 7:35 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $18.37
Real-time Price: $17.95 info
Change: -$0.420 (-2%) info
Market Cap: $2.967B info
DYN
Jun 03, 2026, 7:30 AM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $18.37
Real-time Price: $17.95 info
Change: -$0.420 (-2%) info
Market Cap: $2.967B info
DYN
May 26, 2026, 7:30 AM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $17.50
Real-time Price: $17.95 info
Change: +$0.450 (+3%) info
Market Cap: $2.967B info
DYN
May 21, 2026, 3:14 AM EDT
Source: Wiseek News
Importance Score:
7
Price at Filing: $18.76
Real-time Price: $17.95 info
Change: -$0.8141 (-4%) info
Market Cap: $2.967B info
DYN
May 11, 2026, 7:35 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $17.60
Real-time Price: $17.95 info
Change: +$0.350 (+2%) info
Market Cap: $2.967B info
DYN
May 11, 2026, 7:31 AM EDT
Source: Wiseek News
Importance Score:
8
Price at Filing: $17.60
Real-time Price: $17.95 info
Change: +$0.350 (+2%) info
Market Cap: $2.967B info
DYN
May 11, 2026, 7:25 AM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $17.43
Real-time Price: $17.95 info
Change: +$0.5218 (+3%) info
Market Cap: $2.967B info
DYN
May 06, 2026, 4:43 PM EDT
Filing Type: 144
Importance Score:
7
Price at Filing: $18.84
Real-time Price: $17.95 info
Change: -$0.890 (-5%) info
Market Cap: $2.967B info
DYN
May 05, 2026, 4:39 PM EDT
Filing Type: 144
Importance Score:
7
Price at Filing: $17.47
Real-time Price: $17.95 info
Change: +$0.480 (+3%) info
Market Cap: $2.967B info